BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30706999)

  • 1. Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.
    Narbute K; Piļipenko V; Pupure J; Dzirkale Z; Jonavičė U; Tunaitis V; Kriaučiūnaitė K; Jarmalavičiūtė A; Jansone B; Kluša V; Pivoriūnas A
    Stem Cells Transl Med; 2019 May; 8(5):490-499. PubMed ID: 30706999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-Dependent Memory and Gait Improvement by Intranasally-Administered Extracellular Vesicles in Parkinson's Disease Model Rats.
    Narbute K; Pilipenko V; Pupure J; Klinovičs T; Auders J; Jonavičė U; Kriaučiūnaitė K; Pivoriūnas A; Kluša V
    Cell Mol Neurobiol; 2021 Apr; 41(3):605-613. PubMed ID: 32410106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
    Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W
    Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.
    Cui J; Zhao D; Xu M; Li Z; Qian J; Song N; Wang J; Xie J
    Sci Rep; 2024 Feb; 14(1):3721. PubMed ID: 38355892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease.
    Zhou M; Zhang W; Chang J; Wang J; Zheng W; Yang Y; Wen P; Li M; Xiao H
    Neurosci Lett; 2015 Jan; 584():184-9. PubMed ID: 25449863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease.
    Kumari N; Luthra PM
    Methods Mol Biol; 2024; 2761():491-498. PubMed ID: 38427257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease.
    Tsai WL; Chen HY; Huang YZ; Chen YH; Kuo CW; Chen KY; Hsieh TH
    Behav Neurol; 2019; 2019():4829572. PubMed ID: 31885725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
    Jones CK; Bubser M; Thompson AD; Dickerson JW; Turle-Lorenzo N; Amalric M; Blobaum AL; Bridges TM; Morrison RD; Jadhav S; Engers DW; Italiano K; Bode J; Daniels JS; Lindsley CW; Hopkins CR; Conn PJ; Niswender CM
    J Pharmacol Exp Ther; 2012 Feb; 340(2):404-21. PubMed ID: 22088953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson's Disease.
    Hsueh SC; Chen KY; Lai JH; Wu CC; Yu YW; Luo Y; Hsieh TH; Chiang YH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
    Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.